|
Forecast
Period
|
2024-2028
|
|
Market
Size (2022)
|
USD 23.87 billion
|
|
CAGR
(2023-2028)
|
5.35%
|
|
Fastest
Growing Segment
|
Cardiology
|
|
Largest
Market
|
North
America
|
Market Overview
Global Interventional Imaging Market has valued at USD 23.87 billion in 2022 and is anticipated to project robust growth in the forecast
period with a CAGR of 5.35% through 2028. Interventional imaging has
revolutionized the medical field by providing real-time, image-guided
procedures that ensure high precision and greatly improved patient outcomes.
These cutting-edge techniques have transformed the way medical professionals
diagnose and treat various conditions, from complex surgeries to minimally
invasive procedures.
This robust growth can be attributed to various
factors. Firstly, the global rise in cancer incidence has amplified the demand
for interventional imaging, offering precise diagnostic and treatment solutions
that aid in early detection and effective therapies. The ability to visualize
tumors and precisely target them with therapeutic interventions has
significantly improved patient survival rates.
Additionally, awareness programs and initiatives by
government and healthcare organizations have played a crucial role in
illuminating the benefits of interventional imaging technologies. These
initiatives have helped educate both healthcare professionals and patients on
the potential of these advanced techniques, leading to their widespread
adoption and integration into standard medical practices.
Technological advancements are another pivotal
driver for the market's expansion. Continuous research and development
activities in the field of interventional imaging have resulted in more
advanced and efficient imaging systems. Innovations such as high-resolution
imaging, real-time visualization, and improved image-guidance capabilities have
revolutionized the precision and accuracy of interventional procedures, further
enhancing patient outcomes.
Manufacturers in the interventional imaging
industry are investing heavily in research to develop innovative products that
offer them a competitive edge in the market. This focus on advancing technology
has led to the introduction of state-of-the-art imaging systems with enhanced
functionalities and improved user experience. These advancements not only
benefit healthcare providers but also contribute to the overall growth of the
market.
However, despite the remarkable progress made in
interventional imaging, the market faces some challenges. The high cost of
interventional imaging systems remains a significant barrier, limiting access
to these advanced technologies in certain regions. Additionally, the lack of
skilled professionals trained in interventional imaging techniques poses a
challenge to the widespread adoption and implementation of these procedures.
Key Market Drivers
Rise in Cardiovascular and Neurovascular Interventions
Cardiovascular diseases (CVDs) are the leading
cause of death globally, affecting millions of people every year. According to
the World Health Organization, an estimated 17.9 million people lost their
lives to CVDs in 2019 alone, accounting for a staggering 32% of all global
deaths. This alarming statistic highlights the urgent need for effective
solutions in the field of cardiovascular medicine.
In recent years, minimally invasive cardiovascular
interventions have gained significant traction as a preferred approach for
treatment. These procedures offer several advantages over traditional open
surgery, including reduced risk, shorter recovery time, and improved patient
outcomes. As a result, they have become increasingly prevalent in clinical
practice.
One crucial aspect that underpins the success of
minimally invasive cardiovascular interventions is interventional imaging
technologies. These advanced imaging techniques play a pivotal role in accurate
diagnosis, treatment planning, and real-time guidance during procedures. By
providing high-resolution images, interventional imaging technologies enable
healthcare professionals to navigate complex cardiovascular structures with
precision and ensure optimal patient care.
It is not only cardiovascular conditions that
benefit from minimally invasive interventions. Neurovascular conditions, such
as stroke and aneurysms, also require specialized treatments. The growing
prevalence of these conditions, coupled with advancements in neurovascular
intervention techniques, has fueled a surge in demand for interventional
imaging technologies in this field as well. For instance, endovascular coiling,
a procedure used to block blood flow into an aneurysm, heavily relies on
advanced imaging technologies to guide the accurate placement of the coil.
The increasing adoption of cardiovascular and
neurovascular interventions has created a ripple effect that fuels the growth
of the global interventional imaging market. Manufacturers in the industry are
investing heavily in research and development activities to innovate and
improve their offerings. This includes the development of cutting-edge 3D
imaging technologies and software solutions that provide real-time,
high-resolution images, further enhancing the capabilities of interventional
procedures.
As the demand for cardiovascular and neurovascular
interventions continues to rise, the global interventional imaging market is
poised for sustained growth. Ongoing advancements in technology, coupled with
the increasing preference for minimally invasive procedures, ensure that the
demand for interventional imaging technologies will remain high. With a focus
on innovation and a commitment to improving patient outcomes, the field of
interventional imaging is set to revolutionize the way we diagnose and treat
cardiovascular and neurovascular diseases.
Expansion in Oncology Applications
As the medical community relentlessly strives to
combat this disease, interventional imaging has emerged as a critical and
indispensable tool in the ever-evolving landscape of oncology. With its ability
to provide real-time guidance for an array of minimally invasive procedures
used in cancer treatment, including tumor ablation, biopsy, and targeted drug
delivery, interventional imaging has revolutionized the way clinicians approach
patient care.
These advanced procedures, facilitated by
interventional imaging, allow for precise treatment application, minimizing
damage to healthy tissue and optimizing patient outcomes. By providing
clinicians with real-time images and invaluable insights, interventional
imaging empowers them to perform procedures with enhanced precision and
accuracy, ultimately leading to improved patient care and better long-term
prognosis.
As the role of interventional imaging in oncology
continues to expand, there is a corresponding increase in the demand for
advanced imaging technologies. Recognizing the immense potential and benefits
of these technologies, manufacturers are investing heavily in research and
development to further innovate and improve their product offerings.
One area of focus in this pursuit is the
development of high-resolution 3D imaging technologies and software solutions.
These cutting-edge advancements enable clinicians to obtain highly detailed,
three-dimensional images in real-time, providing them with a comprehensive
understanding of the patient's anatomy and pathology. Armed with this level of
precision and clarity, clinicians can perform procedures with even greater
confidence, ensuring the best possible outcomes for their patients.
These remarkable advancements in interventional
imaging are driving the growth of the global interventional imaging market. As
healthcare providers and institutions increasingly recognize the immense value
and transformative potential of these technologies, the demand for
interventional imaging continues to surge. With ongoing research and
development efforts, we can expect to see even more groundbreaking innovations
in the field of interventional imaging, further revolutionizing the landscape of
oncology and improving patient care worldwide.
Download Free Sample Report
Key Market Challenges
Growing Concerns About Infection Control
Healthcare-associated infections (HAIs) pose a
severe risk to patients, and interventional radiology is not immune to this
phenomenon. The use of imaging equipment across multiple patients increases the
potential for cross-contamination if proper infection prevention and control
(IPC) practices are not followed.
In recent times, concerns about infection control
in interventional imaging have heightened. Radiology departments must now
adhere to strict IPC practices to prevent and control the spread of pathogens.
This includes measures such as thorough disinfection of equipment, proper hand
hygiene, and the use of personal protective equipment (PPE) by healthcare
professionals.
Despite these measures, the challenge persists,
necessitating a more comprehensive approach to infection control in
interventional imaging. This could involve implementing advanced technologies
such as antimicrobial coatings on equipment surfaces, utilizing air filtration
systems, and employing innovative sterilization methods.
The growing concerns around infection control can
potentially impact the global interventional imaging market. For one, it can
increase operational costs as healthcare facilities invest in rigorous IPC
practices. This could include the cost of training staff on infection control
protocols, implementing standardized guidelines, and investing in single-use or
easier-to-clean equipment.
Furthermore, any lapses in infection control could
lead to patient harm, resulting in reputational damage and potential legal
consequences for healthcare providers. This could indirectly affect the
interventional imaging market by reducing trust in these procedures and
impacting demand. Therefore, healthcare facilities and manufacturers must
prioritize infection control efforts to ensure patient safety and maintain the
integrity of interventional imaging practices.
Key Market Trends
Growing Focus on Patient Safety and Radiation Dose
Reduction
Patient safety is of utmost importance in any
medical procedure, and this holds true for interventional imaging as well.
These minimally invasive procedures, while providing several benefits, do carry
potential risks. These risks include exposure to radiation, complications
arising from contrast agents, and procedural complications.
In recent years, there has been a notable shift
towards enhancing patient safety in the field of interventional imaging. This
shift encompasses various aspects, such as improved training for medical
personnel, the development of comprehensive guidelines and protocols to
minimize risks, and the integration of technological advancements to bolster
the safety and efficacy of procedures.
Interventional imaging procedures often involve the
use of ionizing radiation, which can pose a risk to both patients and
healthcare workers. Overexposure to radiation can result in tissue damage and increase
the likelihood of developing cancer.
As a consequence, there is a growing emphasis on
reducing radiation doses in interventional imaging. This reduction is achieved
through a combination of technological advancements, modifications to
procedural techniques, and the implementation of enhanced radiation safety
protocols. For instance, many newly developed imaging systems now incorporate
features that automatically adjust radiation doses, ensuring that only the
minimum necessary dose is utilized.
The focus on patient safety and radiation dose
reduction has had a significant impact on the global interventional imaging
market. It has driven innovation, prompting manufacturers to heavily invest in
research and development to create safer and more effective imaging
technologies.
Healthcare providers are influenced by this trend
when making purchasing decisions, showing a preference for systems that
prioritize patient safety and dose reduction. Additionally, this focus on
safety has also shaped training programs and procedural protocols, placing a
greater emphasis on radiation safety measures.
Segmental Insights
Offering Insights
Based on the category of offering, the CT scanners segment
emerged as the dominant player in the global market for interventional imaging in
2022. Technological advancements have revolutionized the field of medical
imaging, and CT scanners have emerged as a crucial component in diagnostic
procedures. With continuous improvements in resolution, speed, and software, CT
scans have become more accurate and efficient, facilitating precise patient
diagnosis and treatment planning.
In recent years, the development of mobile CT
scanners has further broadened their applications, making them accessible in
various healthcare settings, including global medical missions. These portable
scanners bring diagnostic capabilities to underserved areas, allowing
healthcare professionals to reach patients in remote locations and provide
timely and accurate diagnoses.
As patients become increasingly aware of the
benefits of CT technology, the demand for CT imaging has surged. This demand
stems from the desire for less invasive diagnostic strategies, and CT scanners
effectively fulfill this need. By capturing detailed images of body structures,
CT scans enable healthcare providers to comprehensive obtain a comprehensive
view of the patient's condition, facilitating accurate disease diagnosis and
management.
Application Insights
The cardiology industry segment is projected to
experience rapid growth during the forecast period. One of the primary reasons
for cardiology's dominance in the interventional imaging market is the
increasing prevalence of cardiovascular diseases worldwide. With the rising
numbers of individuals affected by these conditions, there is a growing demand
for diagnostic and interventional procedures that utilize advanced imaging
technologies. Interventional cardiology devices, including cardiac CT scanners,
play a crucial role in accurately diagnosing and effectively managing these
cardiovascular conditions.
Furthermore, the continuous technological
advancements in interventional cardiology have significantly contributed to its
market dominance. The development of more precise and efficient devices has
greatly improved the efficacy of cardiac interventions, leading to their
widespread adoption across the healthcare sector. These advancements empower
healthcare professionals to provide more targeted and successful treatments,
ultimately enhancing patient outcomes.
Moreover, it's important to highlight that
favorable reimbursement policies for interventional cardiology procedures in
certain regions have further fueled the growth of this sector. These policies
create a financially viable environment for healthcare providers to offer these
interventions, leading to an increased prevalence of interventional cardiology
services. As a result, more individuals can access and benefit from these
life-saving procedures, contributing to overall improvements in public health.
Download Free Sample Report
Regional Insights
North America emerged as the dominant player in the
Global Interventional Imaging Market in 2022, holding the largest market share
in terms of value. One of the primary reasons for North America's dominance in
the market is the high prevalence of chronic diseases. These conditions, such
as cardiovascular diseases, cancer, and respiratory disorders, often require
diagnostic and interventional procedures that utilize advanced imaging
technologies. This includes techniques like computed tomography (CT), magnetic
resonance imaging (MRI), and ultrasound, which play a crucial role in accurate
diagnosis and treatment planning.
In addition to the high prevalence of chronic
diseases, the growing geriatric population in North America is another
significant factor contributing to the demand for interventional imaging
procedures. As the population ages, the incidence of age-related health
conditions, such as cardiovascular diseases, osteoarthritis, and
neurodegenerative disorders, increases. These conditions often require
minimally invasive interventions, such as angioplasty, joint injections, and
America's neurointerventions, which rely on interventional radiology techniques
for precise diagnosis and treatment.
Furthermore, North America's quick adoption of
interventional radiology products can be attributed to the region's advanced
healthcare infrastructure and substantial healthcare expenditures. The
availability of state-of-the-art medical facilities, well-equipped hospitals,
and skilled healthcare professionals enables the seamless integration of
innovative interventional radiology technologies. This, in turn, enhances
patient care, improves treatment outcomes, and drives the growth of the
interventional radiology market in North America.
Recent Developments
- In October 2023, Koninklijke Philips NV, a leading
healthcare technology company, unveiled its latest advancements in
point-of-care ultrasound technology at the highly anticipated 2023 American
College of Emergency Physicians Scientific Assembly in Philadelphia, U.S. This
groundbreaking technology promises to revolutionize the way medical
professionals diagnose and treat patients in emergency situations, offering
enhanced imaging capabilities and real-time results.
- In July 2023, Stryker Corporation, a global leader
in medical technology, introduced the Q Guidance System, along with its innovative
cranial guidance software. Designed to support surgeons during cranial
surgeries, this cutting-edge system utilizes image-based planning and provides
real-time guidance, ensuring precise and efficient procedures. This significant
development marks a major milestone in the field of neurosurgery, offering
improved outcomes and patient care.
- In February 2020, Guerbet, a pioneering healthcare
company, achieved official registration from Taiwan's Ministry of Health &
Welfare for its groundbreaking interventional oncology system known as
Vectorio. With its advanced technology and tailored treatment options, Vectorio
represents a significant breakthrough in the field of interventional oncology,
offering new hope to patients and healthcare providers alike.
- In August 2022, Becton Dickinson Korea, a prominent
healthcare solutions provider, announced its acquisition of Bard Korea, a
renowned medical device company, and the subsequent integration of Bard Korea's
legal entity into Becton Dickinson Korea. This strategic merger strengthened
Becton Dickinson Korea's portfolio by integrating Bard's successful medical
device divisions specializing in surgery, interventional procedures, and
oncology. This collaboration enables the company to offer a wider range of innovative
solutions and improve patient outcomes in various medical disciplines.
Key Market Players
- Becton, Dickinson and Company
- Canon
Inc.
- Esaote
SpA
- FUJIFILM
Holdings Corporation
- Hologic,
Inc.
- Intuitive
Surgical, Inc.
- Koninklijke
Philips NV
- Medtronic
plc
- Siemens
Healthineers AG
- Stryker
Corporation
|
By Offering
|
By
Application
|
By Region
|
- CT Scanners
- X-Ray
Systems
- MRI Systems
- Ultrasound
Imaging Systems
- Others
|
- Cardiology
- Neurology
- Musculoskeletal
- Oncology
- Urology
- Gastroenterology
- Obstetrics
- Gynecology
- Others
|
- North
America
- Europe
- Asia Pacific
- South
America
- Middle East
& Africa
|
Report Scope:
In this report, the Global Interventional Imaging
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- Interventional Imaging Market, By Offering:
o CT Scanners
o X-Ray Systems
o MRI Systems
o Ultrasound Imaging Systems
o Others
- Interventional Imaging Market, By Application:
o Cardiology
o Neurology
o Musculoskeletal
o Oncology
o Urology
o Gastroenterology
o Obstetrics
o Gynecology
o Others
- Interventional Imaging Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
§ Turkey
§ Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global
Interventional Imaging Market.
Available Customizations:
Global Interventional Imaging Market report with
the given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Global Interventional
Imaging Market is an upcoming report to be released soon. If you wish an early
delivery of this report or want to confirm the date of release, please contact
us at
[email protected]